EUVIMEDEUVIMED entdecken
Crossref

GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction

Jonathan Goldney, Melanie J Davies

Nature Reviews Gastroenterology & Hepatology · 2024

DOI: 10.1038/s41575-024-00977-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nature Reviews Gastroenterology & Hepatology, 2024. Verfasst von Jonathan Goldney und 1 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Centre, College of Life Sciences, University of Leicester, Leicester, UK. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Hypoglycemic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicHypoglycemic AgentsHumansGlucagon-Like Peptide 1Diabetes Mellitus, Type 2Metabolic DiseasesLiraglutideGlucagon-Like Peptide-1 Receptor Agonists

Substanzen

Hypoglycemic AgentsGlucagon-Like Peptide 1LiraglutideGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Diabetes Research Centre, College of Life Sciences, University of Leicester, Leicester, UK.
  • NIHR Leicester Biomedical Research Centre, University Hospitals of Leicester NHS Trust and University of Leicester, Leicester, UK.
  • Diabetes Research Centre, College of Life Sciences, University of Leicester, Leicester, UK. melanie.davies@uhl-tr.nhs.uk.
  • NIHR Leicester Biomedical Research Centre, University Hospitals of Leicester NHS Trust and University of Leicester, Leicester, UK. melanie.davies@uhl-tr.nhs.uk.

Zitieren

APA

Goldney, J., & Davies, M. J. (2024). GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction. Nature Reviews Gastroenterology & Hepatology. https://doi.org/10.1038/s41575-024-00977-2

Vancouver

Goldney J, Davies MJ. GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction. Nature Reviews Gastroenterology & Hepatology. 2024. doi:10.1038/s41575-024-00977-2

BibTeX
@article{Goldney2024,
  author = {Goldney, Jonathan and Davies, Melanie J},
  title = {GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction},
  journal = {Nature Reviews Gastroenterology & Hepatology},
  year = {2024},
  doi = {10.1038/s41575-024-00977-2}
}
Kostenlos starten →